Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...
Cantor Fitzgerald raised the firm’s price target on Nano-X Imaging (NNOX) to $12 from $11 and keeps an Overweight rating on the shares. After the company received FDA 510(k) expanded indication ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback